孕妇人体肌膜中的β3受体信号表明β3激动剂作为毒解剂的作用
Iain L O Buxton1, Hazik Asif1, Scott D Barnett1
1Myometrial Function Group, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA.
Biomolecules
|June 28, 2023
概括
像Mirabegron这样的β-3 (β3) 激动剂通过放松子宫肌肉,在预防早产方面表现有前途. 与以前的治疗方法不同,mirabegron可能为早产提供了一种新的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生殖医学 生殖医学
- 分子生物学分子生物学
背景情况:
- 早产是婴儿死亡的主要原因,没有可靠的方法来阻止早产.
- 对于喘有效的β-2 (β2) 上腺素受体激动剂由于子宫光滑肌调节的差异而失败.
- 氧化通路虽然可以放松其他光滑肌肉,但在早产过程中是无效的或禁忌的.
研究的目的:
- 为了研究β-3 (β3) 上腺素受体激活剂作为早产期产生的潜在毒解药物的疗效.
- 为了探索人体肌肉中β3AR激动剂的信号传递机制.
- 评估将mirabegron重新用于预防早产的潜力.
主要方法:
- 在体外研究中使用孕妇人类肌肉膜条.
- 用β3激动剂mirabegron来评估其对催产素诱导的收缩的影响.
- 研究氧化的产生和内皮氧化合成酶 (eNOS) 在mirabegron诱导的放松中的作用.
主要成果:
- 米拉贝格朗在人类肌肉组织中显示了催产素诱导的收缩放松作用.
- 米拉贝格伦刺激了肌肉微血管内皮细胞中氧化的产生.
- 通过阻断内皮氧化合成酶,放松效应被部分抑制,这表明氧化的作用.
结论:
- 贝塔-3 (β3) 上腺素受体激动剂,特别是mirabegron,显示出作为新型毒解剂的潜力.
- 米拉贝格朗诱导的肌体松涉及氧化通路,可能通过内皮细胞和光滑肌肉细胞.
- 重新利用mirabegron可以提供一种新的策略来预防早产.
相关概念视频
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
524
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
524
01:26Adrenergic Receptors: β Subtype
1.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.8K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
895
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
895
01:18Adrenergic Agonists: Therapeutic Classification
872
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
872
01:28Antihypertensive Drugs: Types of β-Blockers
763
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
763
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K